Khattar Jack A. sold SUPN

March 13, 2026 · Form 4 insider transaction

Khattar Jack A. sold 24,138 shares of Supernus Pharmaceuticals, Inc. at $50.09 per share, a transaction worth $1.21M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Disposed (sell-side)
Shares
24,138
Price
$50.09
Total value
$1.21M
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 13, 2026
Filing dateMarch 16, 2026
Shares owned after968,962
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.63 to $50.62. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

View the original Form 4 on SEC EDGAR